Orbimed Advisors - 89BIO INC ownership

89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 108 filers reported holding 89BIO INC in Q4 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of 89BIO INC
ValueSharesWeighting
Q4 2022$46,577,402
+119.9%
3,658,8690.0%0.89%
+126.7%
Q3 2022$21,185,000
+79.8%
3,658,8690.0%0.39%
+84.5%
Q2 2022$11,782,000
-14.6%
3,658,8690.0%0.21%
-4.9%
Q1 2022$13,794,000
-71.7%
3,658,869
-1.9%
0.22%
-64.3%
Q4 2021$48,744,000
-33.3%
3,729,4420.0%0.63%
-21.9%
Q3 2021$73,060,000
+4.8%
3,729,4420.0%0.80%
+13.9%
Q2 2021$69,741,000
-21.0%
3,729,4420.0%0.70%
-14.6%
Q1 2021$88,313,000
-2.8%
3,729,4420.0%0.83%
+3.9%
Q4 2020$90,887,000
-5.0%
3,729,4420.0%0.80%
-33.9%
Q3 2020$95,697,000
+19.9%
3,729,442
-6.9%
1.20%
+7.0%
Q2 2020$79,809,000
-21.1%
4,004,4420.0%1.12%
-33.8%
Q1 2020$101,112,000
-4.0%
4,004,4420.0%1.70%
+13.0%
Q4 2019$105,277,0004,004,4421.50%
Other shareholders
89BIO INC shareholders Q4 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 393,548$9,319,0003.36%
RA Capital Management 4,736,214$112,154,0001.69%
Orbimed Advisors 3,729,442$88,313,0000.83%
Pekin Hardy Strauss, Inc. 183,275$4,340,0000.68%
SILVERARC CAPITAL MANAGEMENT, LLC 50,007$1,184,0000.65%
DAFNA Capital Management LLC 105,478$2,498,0000.59%
Parkman Healthcare Partners LLC 102,163$2,419,0000.56%
Eventide Asset Management 1,268,539$30,039,0000.44%
Penn Mutual Asset Management, LLC 16,190$383,0000.43%
Virtus ETF Advisers LLC 11,351$269,0000.11%
View complete list of 89BIO INC shareholders